News Stocks MedPlus Health Services Subsidiary Faces Drug License Suspension Orders in KarnatakaMedPlus Health Services Subsidiary Faces Drug License Suspension Orders in Karnataka
MedPlus Health Services Limited disclosed that its subsidiary Optival Health Solutions Private Limited received drug license suspension orders for two Karnataka stores from the state's Drugs Control Administration. The suspensions, lasting five and seven days respectively, are under Rule 65 of the Drugs and Cosmetics Act, 1940, with a combined potential revenue loss of Rs 4.19 lakhs.
*this image is generated using AI for illustrative purposes only.
MedPlus Health Services Limited has informed stock exchanges about regulatory action taken against its subsidiary regarding drug license suspensions in Karnataka. The company disclosed this development under SEBI Regulation 30 on February 21, 2026.
Regulatory Action Details
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, received two suspension orders from the Assistant Director, Drugs Control Administration, Davanagere Circle, Karnataka. The orders were received on February 20, 2026, and pertain to violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
| Store Location: | Suspension Period | Potential Revenue Loss |
|---|---|---|
| Vinobha Nagar, Karnataka | 5 days | Rs 1.40 lakhs |
| KSRTC Davanagere, Karnataka | 7 days | Rs 2.79 lakhs |
| Total Impact: | 12 days | Rs 4.19 lakhs |
Financial Impact Assessment
The company has quantified the potential financial impact of these suspension orders. The Vinobha Nagar store suspension is expected to result in a revenue loss of Rs 1.40 lakhs, while the KSRTC Davanagere store suspension could lead to a revenue loss of Rs 2.79 lakhs. Combined, the total potential revenue impact amounts to Rs 4.19 lakhs.
Compliance and Disclosure
The disclosure was made in accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The information has been made available on the company's website at www.medplusindia.com and will also be accessible on BSE and NSE websites.
Corporate Communication
The regulatory filing was signed by Manoj Kumar Srivastava, Company Secretary and Compliance Officer of MedPlus Health Services Limited, on February 21, 2026. The communication was addressed to both BSE Limited and National Stock Exchange of India Limited as part of the company's listing obligations.
Historical Stock Returns for Medplus Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.16% | -2.99% | +1.78% | -0.70% | +10.37% | -26.04% |
16
